Evidence map›Paper›PMID 28101869›Full record

ReviewSub-cellular biochemistry2017

Fibrin Formation, Structure and Properties.

John W Weisel, Rustem I Litvinov

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Sub-cellular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05525195 (Influence of Preoperative Fibrinogen Levels on Blood Loss and Transfusions in Pediatric Cardiac Surgery), which is not on this map. Cited by 352 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
352citing papers in PubMed, 1 pooled it
235.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05525195 completednot on this mapstarted 2022, after this paper: background citation

Influence of Preoperative Fibrinogen Levels on Blood Loss and Transfusions in Pediatric Cardiac Surgery

TypeobservationalSponsorBrugmann University HospitalRan2022 to 2023Enrolled932ConditionsCardiac Surgery, Congenital Heart Disease, Cardiopulmonary Bypass, FibrinogenemiaArmsCongenital cardiac surgery
3 · Its place in the literature

Who cites it

352 citing papers in PubMed, 1 synthesis or guideline pooled it, 704 citations in OpenAlex.

  1. Pooled it
  2. Molecular-gated MRIMaterials today. Bio · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Multiple disulfide-bonded states confer extensive conformational diversity in fibrinogen.Protein science : a publication of the Protein Society · 2026
    Article
  19. Article
  20. Article

292 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

John W WeiselDepartment of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. weisel@mail.med.upenn.edu.
Rustem I LitvinovDepartment of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
University of Pennsylvania · US

Funding

Multiscale modeling and empirical study of a mechanism limiting blood clot growthU01HL116330 · NHLBI · UNIVERSITY OF NOTRE DAME · PI ALBER, MARK · 2014 to 2018
$3.5M
Structural origin of fibrin clot mechanical propertiesR01HL090774 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI WEISEL, JOHN W · 2009 to 2012
$1.6M
Structural origin of fibrin clot mechanical propertiesR56HL090774 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI WEISEL, JOHN W · 2014 to 2014
$408k
NHLBI NIH HHS R01 HL090774NHLBI NIH HHS R56 HL090774NHLBI NIH HHS U01 HL116330
6 · The paper itself

Abstract

Fibrinogen and fibrin are essential for hemostasis and are major factors in thrombosis, wound healing, and several other biological functions and pathological conditions. The X-ray crystallographic structure of major parts of fibrin(ogen), together with computational reconstructions of missing portions and numerous biochemical and biophysical studies, have provided a wealth of data to interpret molecular mechanisms of fibrin formation, its organization, and properties. On cleavage of fibrinopeptides by thrombin, fibrinogen is converted to fibrin monomers, which interact via knobs exposed by fibrinopeptide removal in the central region, with holes always exposed at the ends of the molecules. The resulting half-staggered, double-stranded oligomers lengthen into protofibrils, which aggregate laterally to make fibers, which then branch to yield a three-dimensional network. Much is now known about the structural origins of clot mechanical properties, including changes in fiber orientation, stretching and buckling, and forced unfolding of molecular domains. Studies of congenital fibrinogen variants and post-translational modifications have increased our understanding of the structure and functions of fibrin(ogen). The fibrinolytic system, with the zymogen plasminogen binding to fibrin together with tissue-type plasminogen activator to promote activation to the active proteolytic enzyme, plasmin, results in digestion of fibrin at specific lysine residues. In spite of a great increase in our knowledge of all these interconnected processes, much about the molecular mechanisms of the biological functions of fibrin(ogen) remains unknown, including some basic aspects of clotting, fibrinolysis, and molecular origins of fibrin mechanical properties. Even less is known concerning more complex (patho)physiological implications of fibrinogen and fibrin.

Indexed as

AnimalsFibrinFibrinogenHumansProtein ConformationFibrinFibrinogenBlood clotClot mechanical propertiesFibrin formationFibrinogen compositionFibrin polymerizationFibrin propertiesFibrin structureModulation of clot structureMolecular mechanisms of fibrinolysisα-Helical coiled-coil

Identifiers

PMID28101869
PMCPMC5536120
OpenAlexW2572149156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.